The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

Six-month open-label study showed clinically meaningful improvements in kidney function and disease in patients with Type 2 diabetic nephropathy. 71% achieved a >30% reduction in UP/Cr, a key ...

36% had reduced urinary synaptopodin losses, indicating healthier kidney cells and structure. "The positive results from our Phase 2b study evaluating a melanocortin agonist in patients with diabetic ...

Both compounds can be distinguished from typical D 2 agonists, however, because they do not cause behavioral signs associated with activation of either normosensitive or supersensitive ...

About KGF alternative peptide (FGFR2b agonist) [Product code: PG-012] Mechanism of activating FGFR2b by the KGF alternative peptide (PG-012) PG-012, KGF alternative peptide, is a dimeric peptide ...

(Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel synthetic peptide called "KGF alternative- peptide (FGFR2b agonist)" which is functionally ...

The data also showed that low dose MC4R agonist bremelanotide stopped the rapid weight regain seen after ending GLP-1/GIP tirzepatide treatment." Topline data results from the study were highly ...

Auto news: 'Not all hybrid vehicles deliver fuel savings compared to their petrol counterparts' © 2025 Nine Entertainment Co.